Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P Biotech ETF
XBI
|
+$284M |
| 2 |
Constellation Brands
STZ
|
+$284M |
| 3 |
Stellantis
STLA
|
+$268M |
| 4 |
VMW
VMware, Inc
VMW
|
+$263M |
| 5 |
NiSource
NI
|
+$234M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.82B |
| 2 |
Apple
AAPL
|
+$1.62B |
| 3 |
UnitedHealth
UNH
|
+$1.03B |
| 4 |
ExxonMobil
XOM
|
+$869M |
| 5 |
Tesla
TSLA
|
+$701M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.19% |
| 2 | Consumer Discretionary | 5.03% |
| 3 | Healthcare | 4.78% |
| 4 | Financials | 4.74% |
| 5 | Communication Services | 2.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1151
CALL
Baker Hughes
BKR
$60B
| $10.1M | ﹤0.01% |
+350,600
| New | +$10.6M |
|
1152
VF Corp
VFC
$5.63B
| $10.1M | ﹤0.01% |
441,111
-114,552
| -21% | -$3.01M |
|
1153
PUT
ArcelorMittal
MT
$52.9B
| $10.1M | ﹤0.01% |
334,600
-495,000
| -60% | -$14.7M |
|
1154
CALL
Shopify
SHOP
$152B
| $10M | ﹤0.01% |
209,600
+176,600
| +535% | +$7.77M |
|
1155
Immunocore
IMCR
$1.72B
| $10M | ﹤0.01% |
202,984
+5,856
| +3% | +$329K |
|
1156
Markel Group
MKL
$23.3B
| $10M | ﹤0.01% |
7,846
-5,031
| -39% | -$6.68M |
|
1157
Kohl's
KSS
$2.17B
| $10M | ﹤0.01% |
425,435
-286,270
| -40% | -$8.07M |
|
1158
Deckers Outdoor
DECK
$13.2B
| $9.97M | ﹤0.01% |
133,056
+77,856
| +141% | +$5.44M |
|
1159
Carlisle Companies
CSL
$14.3B
| $9.97M | ﹤0.01% |
44,092
-2,807
| -6% | -$683K |
|
|
K
1160
PUT
DELISTED
Kellanova
K
| $9.94M | ﹤0.01% |
158,153
-44,623
| -22% | -$2.82M |
|
1161
PUT
Avis
CAR
$4.86B
| $9.93M | ﹤0.01% |
+51,000
| New | +$10.2M |
|
1162
Hubbell
HUBB
$25B
| $9.89M | ﹤0.01% |
40,628
-6,855
| -14% | -$1.64M |
|
|
VTNR
1163
PUT
DELISTED
Vertex Energy, Inc
VTNR
| $9.88M | ﹤0.01% |
1,000,000
| – | – |
|
1164
Charles River Laboratories
CRL
$11.2B
| $9.86M | ﹤0.01% |
48,863
-17,913
| -27% | -$4.06M |
|
1165
CALL
Analog Devices
ADI
$179B
| $9.86M | ﹤0.01% |
+50,000
| New | +$8.96M |
|
1166
Liberty Media Series C
FWONK
$24.6B
| $9.85M | ﹤0.01% |
136,164
-181,566
| -57% | -$12.3M |
|
1167
Bath & Body Works
BBWI
$4.06B
| $9.83M | ﹤0.01% |
268,698
-319,066
| -54% | -$13.4M |
|
1168
PUT
AstraZeneca
AZN
$263B
| $9.82M | ﹤0.01% |
70,750
+30,000
| +74% | +$4.04M |
|
1169
United Therapeutics
UTHR
$25.8B
| $9.79M | ﹤0.01% |
43,692
+12,931
| +42% | +$3.19M |
|
1170
Fluor
FLR
$7.01B
| $9.77M | ﹤0.01% |
316,135
-184,443
| -37% | -$6.34M |
|
1171
Jazz Pharmaceuticals
JAZZ
$15.9B
| $9.76M | ﹤0.01% |
66,681
-6,268
| -9% | -$927K |
|
|
PXD
1172
PUT
DELISTED
Pioneer Natural Resource Co.
PXD
| $9.74M | ﹤0.01% |
47,700
+44,900
| +1,604% | +$9.65M |
|
1173
Commercial Metals
CMC
$7.6B
| $9.73M | ﹤0.01% |
198,929
+29,589
| +17% | +$1.53M |
|
|
AYX
1174
DELISTED
Alteryx Inc
AYX
| $9.72M | ﹤0.01% |
165,159
-275,585
| -63% | -$16.1M |
|
1175
QuantumScape Corp
QS
$3.21B
| $9.66M | ﹤0.01% |
1,180,909
-815,603
| -41% | -$6.62M |
|
Similar funds
Barclays's Q1 2023 Portfolio in Review
As of Q1 2023, Barclays held 5,603 positions worth $218B, down 2.4% from $223B the previous quarter. Its ten largest holdings account for 47% of the portfolio.
Barclays withdrew a net $25.1B in Q1 2023, closing 541 positions and reducing 1,667 holdings. Its most notable exit was Coupa Software Incorporated, an estimated $128M position sold in full.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 12% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Barclays opened a new position in GE HealthCare worth $40.7M.
- Barclays's largest Q1 2023 buy was GE HealthCare: 496,712 shares worth $40.7M.
- Barclays added most to State Street SPDR S&P Biotech ETF in Q1 2023, an estimated $284M increase.
- Barclays's biggest Q1 2023 reduction was Microsoft, cutting an estimated $1.82B.
- Barclays fully exited Coupa Software Incorporated in Q1 2023, selling an estimated $128M.
- Barclays's ten largest holdings make up 47% of its $218B portfolio in Q1 2023.
- Barclays opened 345 new positions and closed 541 in Q1 2023.
- Barclays's portfolio value fell 2.4% quarter-over-quarter to $218B.
Based on Barclays's 13F filing for Q1 2023, filed 4 May 2023.